Birmingham, UK and Albuquerque, NM, US (3 June 2024) – Indica Labs and Histofy have come together in a collaboration aimed at bringing Histofy’s cutting-edge AI tools into clinical practice via the established HALO AP® platform.
Histofy and Indica Labs Partner to Introduce AI Solutions to Pathology Practice Read More »
Albuquerque, NM, December 17, 2025 – Indica Labs, the global leader in AI-powered digital pathology, announced today that clinical revenue growth rate for HALO AP® is up 260% since 2023 and recurring revenue for 2025 shows a 200% increase year-over-year, reinforcing its position as a market leader in digital pathology diagnostics.
Indica Labs Reports 260% Clinical Revenue Growth and Expansion into New Global Markets Read More »
As 2024 draws to a close, we at Indica Labs would like to thank the customers and collaborators who helped fill 2024 with exciting discoveries, events, and partnerships. It is a great honor to have played a part in customers’ contributions to scientific fields ranging from immuno-oncology to infectious disease, immunology, neuroscience, and metabolism.
Looking Back: Reviewing 2024 at Indica Labs Read More »
At Indica Labs, we’ve built aa ecosystem of partnerships to promote open pathology and interoperability, enabling our customers to choose best-of-breed products across integrated digital pathology workflows.
From discovery to diagnostics, AI powers our entire HALO software suite and services. Advance your pathology research with our AI-powered image analysis and collaborative image management platforms.
AI-Powered Pathology Read More »
